Page last updated: 2024-12-04

1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

The compound you described, **1-(4-methanesulfonamidophenoxy)-3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol**, is a **β-blocker**. This means it works by blocking the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) on the heart and blood vessels.

Here's why it's important for research:

* **Understanding β-blockers:** This compound could be used in research to study the mechanisms of action of β-blockers. It could help scientists understand how these drugs interact with specific receptors in the body and how they affect various physiological processes.
* **Developing new β-blockers:** The compound could serve as a starting point for the development of new and improved β-blockers with better efficacy, fewer side effects, or tailored for specific applications.
* **Investigating other biological targets:** β-blockers can have effects beyond their primary function of blocking adrenaline and noradrenaline. This compound could be used to investigate other potential therapeutic targets for which β-blockers might be useful, like neuroprotection or anti-cancer effects.

However, it's important to note that:

* **This is a specific chemical compound, not a drug.** It hasn't been approved for clinical use, and its safety and efficacy haven't been fully established.
* **Research with this compound would be conducted in a laboratory setting** using appropriate safety protocols and ethical guidelines.

If you're interested in learning more about β-blockers or specific research related to this compound, you can search scientific databases like PubMed, Google Scholar, or consult relevant publications in medical and pharmacological journals.

Cross-References

ID SourceID
PubMed CID2129
CHEMBL ID43527
CHEBI ID91532
SCHEMBL ID9655059
MeSH IDM0223743

Synonyms (38)

Synonym
CBIOL_001738
BRD-A11813248-001-02-8
BIO2_000288 ,
BIO1_000024
BIO1_001002
BIO1_000513
BIO2_000768
BSPBIO_001568
IDI1_034038
NCGC00024837-03
NCGC00024837-02
KBIO3_000575
KBIOSS_000288
KBIO2_002856
KBIO2_005424
KBIO3_000576
KBIOGR_000288
KBIO2_000288
NCGC00024837-04
HMS1989O10
CHEMBL43527
HMS1791O10
133229-23-9
n-(4-(3-((2-(3,4-dichlorophenyl)ethyl)methylamino)-2-hydroxypropoxy)phenyl)methanesulfonamide
unii-rv6721i4h5
rv6721i4h5 ,
1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol
msaph-2clphea-2-propanol
methanesulfonamide, n-(4-(3-((2-(3,4-dichlorophenyl)ethyl)methylamino)-2-hydroxypropoxy)phenyl)-
AC-115
SCHEMBL9655059
CHEBI:91532
Q27163366
n-[4-(3-{[2-(3,4-dichloro-phenyl)-ethyl]-methyl-amino}-2-hydroxy-propoxy)-phenyl]-methanesulfonamide
DTXSID10928009
n-[4-(3-{[2-(3,4-dichlorophenyl)ethyl](methyl)amino}-2-hydroxypropoxy)phenyl]methanesulfonamide
BRD-A11813248-003-01-6
n-(4-(3-((3,4-dichlorophenethyl)(methyl)amino)-2-hydroxypropoxy)phenyl)methanesulfonamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency20.73290.000811.382244.6684AID686978; AID686979
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.54810.035520.977089.1251AID504332
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID391340Anticonvulsant activity in Sprague-Dawley rat assessed as inhibition of electroshock-induced tonic hind limb extension at 30 mg/kg, ip administered 30 mins before electroshock2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
AID324536Increase in light chain 3-GFP+ autophagosome vesicle intensity per cell in human H4 cells at 5.2 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1138325Inhibition of [86]-Rb+-efflux in rat INS-1E cells at 10'8 to 10'6 M incubated for 30 mins followed by high-phosphate buffer addition by scintillation counting analysis2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of a truncated cardiotoxin-I analogue with potent insulinotropic activity.
AID324583Increase in long-lived protein degradation in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324577Effect on FYVE-RFP+ vesicle intensity per cell in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324578Effect on FYVE-RFP+ vesicle intensity per cell in human H4 cells after 8 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324380Induction of light chain 3-GFP level in human H4 cells at 5.2 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324432Increase in light chain 3-GFP+ autophagosome vesicle number per cell in human H4 cells at 5.2 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID391055Inhibition of rat NR1/NR2B(E201R) mutant receptor expressed in Xenopus oocytes at 100 nM by two electrode voltage clamp method2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
AID391056Inhibition of rat wild type NR1/NR2B receptor expressed in Xenopus oocytes at 100 nM by two electrode voltage clamp method2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
AID75637Compound was evaluated for the increase in duration or cardiac APD (action potential duration) at 90% repolarization, using isolated guinea pig ventricular myocytes at concentration of 1 nM1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
The synthesis and potassium channel blocking activity of some (4-methanesulfonamidophenoxy)propanolamines as potential class III antiarrhythmic agents.
AID75636Compound was evaluated for the increase in duration or cardiac APD (action potential duration) at 90% repolarization, using isolated guinea pig ventricular myocytes at concentration of 10 nM1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
The synthesis and potassium channel blocking activity of some (4-methanesulfonamidophenoxy)propanolamines as potential class III antiarrhythmic agents.
AID324484Increase in light chain 3-GFP+ autophagosome vesicle area per cell in human H4 cells at 5.2 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324585Increase in long-lived protein degradation in human H4 cells after 24 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324584Increase in long-lived protein degradation in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID75631Compound was evaluated for the increase in duration or cardiac APD (action potential duration) at 90% repolarization, using isolated guinea pig ventricular myocytes at concentration of 100 nM1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
The synthesis and potassium channel blocking activity of some (4-methanesulfonamidophenoxy)propanolamines as potential class III antiarrhythmic agents.
AID324582Increase in long-lived protein degradation in human H4 cells after 1 hr relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324576Effect on FYVE-RFP+ vesicle intensity per cell in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID391057Inhibition of rat NR1(H134A)/NR2B mutant receptor expressed in Xenopus oocytes at 100 nM by two electrode voltage clamp method2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's2 (20.00)29.6817
2010's2 (20.00)24.3611
2020's2 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]